ESC Premium Access

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial

Event: ESC Congress 2021 - The Digital Experience
Topic: Clinical
Session type: Official Joint Session
Date: 27 August 2021
Time: 09:30 - 10:15

Congress Session

Become an ESC member to access this resource

Become a member

Already a member? Sign in

5 presentations in this session

Beyond the ISCHEMIA paradigm: updating the role of stress tests, coronary CT and optimisation of medical therapy.

Speaker: Assistant Professor S. Kohsaka (Tokyo, JP)
Thumbnail

How should we manage chronic coronary syndromes after the ISCHEMIA trial?

Speaker: Doctor F. Otsuka (Suita, JP)
Thumbnail

Is there a need to revise the ESC Guidelines for myocardial revascularisation and chronic coronary syndromes because of the ISCHEMIA trial?

Speaker: Doctor B. Gersh (Rochester, US)
Thumbnail

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial – discussion.

Thumbnail

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial - Chat Moderator.

Thumbnail

3 speakers from this session

Assistant Professor Shun Kohsaka

Keio University School of Medicine, Tokyo (Japan)
1 presentation
0 follower

Doctor Fumiyuki Otsuka

, Suita (Japan)
1 presentation
0 follower

Doctor Bernard Gersh

Mayo Clinic, Rochester (United States of America)
5 presentations
0 follower

Related content

ESC Premium Access

ESC Guidelines 2021 - Valvular Heart Disease

3 December 2021

ESC Premium Access

ESC Guidelines 2021 - Heart Failure

3 December 2021

ESC Premium Access

Pregnancy in women with cardiovascular disease

3 December 2021

This platform is supported by

logo Novo Nordisk